BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, Zhang L, Shih WJ, Celià-Terrassa T, Liu Y, Cristea I, Shao ZM, Kang Y. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell 2019;35:64-80.e7. [PMID: 30612941 DOI: 10.1016/j.ccell.2018.11.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhao G, Yuan H, Li Q, Zhang J, Guo Y, Feng T, Gu R, Ou D, Li S, Li K, Lin P. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal Transduct Target Ther 2022;7:275. [PMID: 35973989 DOI: 10.1038/s41392-022-01096-7] [Reference Citation Analysis]
2 Wang Z, Zhu J, Liu Y, Wang Z, Cao X, Gu Y. Tumor-polarized GPX3+ AT2 lung epithelial cells promote premetastatic niche formation. Proc Natl Acad Sci U S A 2022;119:e2201899119. [PMID: 35914155 DOI: 10.1073/pnas.2201899119] [Reference Citation Analysis]
3 Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL, Wyllie K, Tran E, Mok E, Nadalini A, Skhinas JN, Lucas MC, Herrmann D, Nobis M, Pereira BA, Law AMK, Castillo L, Murphy KJ, Zaratzian A, Hastings JF, Croucher DR, Lim E, Oliver BG, Mora FV, Parker BL, Gallego-Ortega D, Swarbrick A, O'Toole S, Timpson P, Cox TR. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun 2022;13:4587. [PMID: 35933466 DOI: 10.1038/s41467-022-32255-7] [Reference Citation Analysis]
4 Strauss P, Rivedal M, Scherer A, Eikrem Ø, Nakken S, Beisland C, Bostad L, Flatberg A, Skandalou E, Beisvåg V, Furriol J, Marti HP. A multiomics disease progression signature of low-risk ccRCC. Sci Rep 2022;12:13503. [PMID: 35931808 DOI: 10.1038/s41598-022-17755-2] [Reference Citation Analysis]
5 Liang Y, Zhou X, Xie Q, Sun H, Huang K, Chen H, Wang W, Zhou B, Wei X, Zeng D, Lin H. CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215856] [Reference Citation Analysis]
6 Cuellar-vite L, Weber-bonk KL, Abdul-karim FW, Booth CN, Keri RA. Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy. Cancers 2022;14:3374. [DOI: 10.3390/cancers14143374] [Reference Citation Analysis]
7 Liu Y, Ma X, Zhu Y, Lv X, Wang P, Feng L. pH-responsive nanomedicine co-encapsulated with Erlotinib and chlorin e6 can enable effective treatment of triple negative breast cancer via reprogramming tumor vasculature. Chemical Engineering Journal 2022;437:135305. [DOI: 10.1016/j.cej.2022.135305] [Reference Citation Analysis]
8 Law AMK, Chen J, Colino-Sanguino Y, Fuente LR, Fang G, Grimes SM, Lu H, Huang RJ, Boyle ST, Venhuizen J, Castillo L, Tavakoli J, Skhinas JN, Millar EKA, Beretov J, Rossello FJ, Tipper JL, Ormandy CJ, Samuel MS, Cox TR, Martelotto L, Jin D, Valdes-Mora F, Ji HP, Gallego-Ortega D. ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. Adv Sci (Weinh) 2022;:e2103332. [PMID: 35611998 DOI: 10.1002/advs.202103332] [Reference Citation Analysis]
9 Mani S, Hande A, Boichuk S. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies. BioNanoSci . [DOI: 10.1007/s12668-022-00991-1] [Reference Citation Analysis]
10 Li J, Chen D, Shen M. Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses. Front Med 2022;9:869010. [DOI: 10.3389/fmed.2022.869010] [Reference Citation Analysis]
11 Shao S, Piao L, Wang J, Guo L, Wang J, Wang L, Tong L, Yuan X, Han X, Fang S, Zhu J, Wang Y. Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway. Front Oncol 2022;12:774988. [PMID: 35280793 DOI: 10.3389/fonc.2022.774988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tian WQ, Chen SY, Chuan FN, Zhao WR, Zhou B. Down-regulated TINAGL1 in fibroblasts impairs wound healing in diabetes. FASEB J 2022;36:e22235. [PMID: 35199864 DOI: 10.1096/fj.202101438RR] [Reference Citation Analysis]
13 Gonzalez H, Mei W, Robles I, Hagerling C, Allen BM, Hauge Okholm TL, Nanjaraj A, Verbeek T, Kalavacherla S, van Gogh M, Georgiou S, Daras M, Phillips JJ, Spitzer MH, Roose JP, Werb Z. Cellular architecture of human brain metastases. Cell 2022;185:729-745.e20. [PMID: 35063085 DOI: 10.1016/j.cell.2021.12.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wang T, Yang L, Li C, Wang J, Zhang J, Zhou Y, Sun F, Wang H, Ma F, Qian H. Comprehensive analysis reveals GRP94 is associated with worse prognosis of breast cancer. Transl Cancer Res 2021;10:298-309. [PMID: 35116261 DOI: 10.21037/tcr-20-1853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Moritz MNDO, Casali BC, Stotzer US, Karina dos Santos P, Selistre-de-araujo HS. Alternagin-C, an alpha2beta1 integrin ligand, attenuates collagen-based adhesion, stimulating the metastasis suppressor 1 expression in triple-negative breast tumor cells. Toxicon 2022. [DOI: 10.1016/j.toxicon.2022.02.001] [Reference Citation Analysis]
16 Si Y, Chen K, Ngo HG, Guan JS, Totoro A, Zhou Z, Kim S, Kim T, Zhou L, Liu X. Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers. Pharmaceutics 2022;14:146. [PMID: 35057042 DOI: 10.3390/pharmaceutics14010146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shen M, Smith HA, Wei Y, Jiang YZ, Zhao S, Wang N, Rowicki M, Tang Y, Hang X, Wu S, Wan L, Shao ZM, Kang Y. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nat Cancer 2022;3:60-74. [PMID: 35121988 DOI: 10.1038/s43018-021-00280-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
18 Shen M, Wei Y, Kim H, Wan L, Jiang YZ, Hang X, Raba M, Remiszewski S, Rowicki M, Wu CG, Wu S, Zhang L, Lu X, Yuan M, Smith HA, Zheng A, Bertino J, Jin JF, Xing Y, Shao ZM, Kang Y. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis. Nat Cancer 2022;3:43-59. [PMID: 35121987 DOI: 10.1038/s43018-021-00279-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
19 Freeman JW. Structural Biology of the Tumor Microenvironment. Adv Exp Med Biol 2021;1350:91-100. [PMID: 34888845 DOI: 10.1007/978-3-030-83282-7_4] [Reference Citation Analysis]
20 Qiu X, Qu Y, Guo B, Zheng H, Meng F, Zhong Z. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release 2021;341:498-510. [PMID: 34883139 DOI: 10.1016/j.jconrel.2021.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
21 Trombetta-Lima M, Rosa-Fernandes L, Angeli CB, Moretti IF, Franco YM, Mousessian AS, Wakamatsu A, Lerario AM, Oba-Shinjo SM, Pasqualucci CA, Marie SKN, Palmisano G. Extracellular Matrix Proteome Remodeling in Human Glioblastoma and Medulloblastoma. J Proteome Res 2021;20:4693-707. [PMID: 34533964 DOI: 10.1021/acs.jproteome.1c00251] [Reference Citation Analysis]
22 He J, Zhang S, Qiu Z, Li X, Huang H, Jin W, Xu Y, Shao G, Wang L, Meng J, Wang S, Geng X, Jia Y, Li M, Yang B, Jenny Lu HA, Zhou H. Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model. J Am Soc Nephrol 2021;32:2159-74. [PMID: 34465607 DOI: 10.1681/ASN.2020111560] [Reference Citation Analysis]
23 Liu N, Wang X, Li X, Lv X, Xie H, Guo Z, Wang J, Dou G, Du Y, Song D. Identification of effective natural PIK3CA H1047R inhibitors by computational study. Aging (Albany NY) 2021;13:20246-57. [PMID: 34415239 DOI: 10.18632/aging.203409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Li K, Zhang TT, Zhao CX, Wang F, Cui B, Yang ZN, Lv XX, Yeerjiang Z, Yuan YF, Yu JM, Wang ZH, Zhang XW, Yu JJ, Liu SS, Shang S, Huang B, Hua F, Hu ZW. Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. Sci Transl Med 2021;13:eabb2914. [PMID: 33762435 DOI: 10.1126/scitranslmed.abb2914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hua Z, White J, Zhou J. Cancer stem cells in TNBC. Semin Cancer Biol 2021:S1044-579X(21)00185-1. [PMID: 34147641 DOI: 10.1016/j.semcancer.2021.06.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
26 Shen M, Kang Y. Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities. Genes Dev 2020;34:1577-98. [PMID: 33262145 DOI: 10.1101/gad.343251.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Li X, Wang H, Yang X, Wang X, Zhao L, Zou L, Yang Q, Hou Z, Tan J, Zhang H, Nie J, Jiao B. GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling. Cancer Lett 2021;514:90-102. [PMID: 34023418 DOI: 10.1016/j.canlet.2021.04.028] [Reference Citation Analysis]
28 Valdembri D, Serini G. The roles of integrins in cancer. Fac Rev 2021;10:45. [PMID: 34131655 DOI: 10.12703/r/10-45] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Musetti SN, Huang L. Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer. Mol Pharm 2021;18:2032-8. [PMID: 33877834 DOI: 10.1021/acs.molpharmaceut.1c00008] [Reference Citation Analysis]
30 Esposito M, Fang C, Cook KC, Park N, Wei Y, Spadazzi C, Bracha D, Gunaratna RT, Laevsky G, DeCoste CJ, Slabodkin H, Brangwynne CP, Cristea IM, Kang Y. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nat Cell Biol 2021;23:257-67. [PMID: 33723425 DOI: 10.1038/s41556-021-00641-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Zhang N, Hao J, Cai Y, Wang M. Research advances of secretory proteins in malignant tumors. Chin J Cancer Res 2021;33:115-32. [PMID: 33707934 DOI: 10.21147/j.issn.1000-9604.2021.01.12] [Reference Citation Analysis]
32 Ma J, Yang Y, Wang L, Jia X, Lu T, Zeng Y, Liu L, Gao Y. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer. Aging (Albany NY) 2021;13:7211-27. [PMID: 33639614 DOI: 10.18632/aging.202579] [Reference Citation Analysis]
33 Rigiracciolo DC, Cirillo F, Talia M, Muglia L, Gutkind JS, Maggiolini M, Lappano R. Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression. Cancers (Basel) 2021;13:645. [PMID: 33562737 DOI: 10.3390/cancers13040645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Cheng FY, Chan CH, Wang BJ, Yeh YL, Wang YJ, Chiu HW. The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:606. [PMID: 33546453 DOI: 10.3390/cancers13040606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wang A, Liu J, Yang Y, Chen Z, Gao C, Wang Z, Fu C, Zou L, Wang S. Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells. Chin Med 2021;16:16. [PMID: 33526051 DOI: 10.1186/s13020-021-00426-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Yousefi H, Vatanmakanian M, Mahdiannasser M, Mashouri L, Alahari NV, Monjezi MR, Ilbeigi S, Alahari SK. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene 2021;40:1043-63. [PMID: 33420366 DOI: 10.1038/s41388-020-01588-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
37 Yang Y, Chen X, Ma C. Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility. J Biomed Res 2020;35:189-96. [PMID: 33911052 DOI: 10.7555/JBR.34.20200082] [Reference Citation Analysis]
38 Hou J, Yan D, Liu Y, Huang P, Cui H. The Roles of Integrin α5β1 in Human Cancer. Onco Targets Ther 2020;13:13329-44. [PMID: 33408483 DOI: 10.2147/OTT.S273803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zhao K, Li Y, Han T, Sun A, Bian W, Li M, Lin Q, Shao G. Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer. Oncol Lett 2021;21:102. [PMID: 33376535 DOI: 10.3892/ol.2020.12363] [Reference Citation Analysis]
40 Zhang L, Zhao D, Wang Y, Zhang W, Zhang J, Fan J, Zhan Q, Chen J. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network. Mol Carcinog 2021;60:113-24. [PMID: 33283357 DOI: 10.1002/mc.23273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Jao TM, Fang WH, Ciou SC, Yu SL, Hung YL, Weng WT, Lin TY, Tsai MH, Yang YC. PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer. Cancer Lett 2021;499:290-300. [PMID: 33271263 DOI: 10.1016/j.canlet.2020.11.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Chen S, Youhong T, Tan Y, He Y, Ban Y, Cai J, Li X, Xiong W, Zeng Z, Li G, Yi M, Liu W, Xiang B. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2. Carcinogenesis 2020;41:723-33. [PMID: 31665243 DOI: 10.1093/carcin/bgz180] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
43 Wu G, Zhou H, Li D, Zhi Y, Liu Y, Li J, Wang F. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis. Exp Cell Res 2020;396:112331. [PMID: 33058834 DOI: 10.1016/j.yexcr.2020.112331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
44 Si Y, Xu Y, Guan J, Chen K, Kim S, Yang ES, Zhou L, Liu XM. Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy. Eng Life Sci 2021;21:37-44. [PMID: 33531889 DOI: 10.1002/elsc.202000027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Sun Z, Zeng B, Liu D, Zhao Q, Wang J, Rosie Xing H. S100A8 transported by SEC23A inhibits metastatic colonization via autocrine activation of autophagy. Cell Death Dis 2020;11:650. [PMID: 32811814 DOI: 10.1038/s41419-020-02835-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Shan ZG, Sun ZW, Zhao LQ, Gou Q, Chen ZF, Zhang JY, Chen W, Su CY, You N, Zhuang Y, Zhao YL. Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression. J Gastroenterol Hepatol 2021;36:196-203. [PMID: 32537806 DOI: 10.1111/jgh.15150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Ye Y, Zhang R, Feng H. Fibronectin promotes tumor cells growth and drugs resistance through a CDC42-YAP-dependent signaling pathway in colorectal cancer. Cell Biol Int 2020;44:1840-9. [PMID: 32437085 DOI: 10.1002/cbin.11390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
48 Paul R, Luo M, Mo X, Lu J, Yeo SK, Guan JL. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors. Breast Cancer Res 2020;22:59. [PMID: 32493400 DOI: 10.1186/s13058-020-01298-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Sun NY, Yang MH. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy. Front Oncol 2020;10:792. [PMID: 32509584 DOI: 10.3389/fonc.2020.00792] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
50 Jia Q, Zhang X, Zhang A, Wu R, Liu Z, Chen Y, Wang J, Lv L. rLj-RGD4, the shortened peptide of rLj-RGD3 from Lampetra japonica, protects against cerebral ischemia/reperfusion injury via the PI3K/Akt pathway. Peptides 2020;129:170310. [PMID: 32389578 DOI: 10.1016/j.peptides.2020.170310] [Reference Citation Analysis]
51 Javadi S, Zhiani M, Mousavi MA, Fathi M. Crosstalk between Epidermal Growth Factor Receptors (EGFR) and integrins in resistance to EGFR tyrosine kinase inhibitors (TKIs) in solid tumors. Eur J Cell Biol 2020;99:151083. [PMID: 32381360 DOI: 10.1016/j.ejcb.2020.151083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
52 Lev S. Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochemical Society Transactions 2020;48:657-65. [DOI: 10.1042/bst20191055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
53 Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, Gutkind JS, Maggiolini M. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells 2020;9:E1010. [PMID: 32325700 DOI: 10.3390/cells9041010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
54 Li JW, Li N, Jiang YZ, Liu YR, Shi ZT, Chang C, Shao ZM. Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis. Ann Transl Med 2020;8:435. [PMID: 32395479 DOI: 10.21037/atm.2020.03.204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
55 Hebert JD, Myers SA, Naba A, Abbruzzese G, Lamar JM, Carr SA, Hynes RO. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches. Cancer Res 2020;80:1475-85. [PMID: 32019869 DOI: 10.1158/0008-5472.CAN-19-2961] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 11.5] [Reference Citation Analysis]
56 Akaiwa M, Fukui E, Matsumoto H. Tubulointerstitial nephritis antigen-like 1 deficiency alleviates age-dependent depressed ovulation associated with ovarian collagen deposition in mice. Reprod Med Biol 2020;19:50-7. [PMID: 31956285 DOI: 10.1002/rmb2.12301] [Reference Citation Analysis]
57 Elgundi Z, Papanicolaou M, Major G, Cox TR, Melrose J, Whitelock JM, Farrugia BL. Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan. Front Oncol 2019;9:1482. [PMID: 32010611 DOI: 10.3389/fonc.2019.01482] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
58 Shahi Thakuri P, Gupta M, Singh S, Joshi R, Glasgow E, Lekan A, Agarwal S, Luker GD, Tavana H. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling. BMC Cancer 2020;20:4. [PMID: 31898540 DOI: 10.1186/s12885-019-6479-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
59 Jing W, Guo X, Wang G, Bi Y, Han L, Zhu Q, Qiu C, Tanaka M, Zhao Y. Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages. Int Immunopharmacol 2020;78:106012. [PMID: 31865052 DOI: 10.1016/j.intimp.2019.106012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
60 Rontogianni S, Iskit S, van Doorn S, Peeper DS, Altelaar M. Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux. Mol Cell Proteomics 2020;19:261-77. [PMID: 31772060 DOI: 10.1074/mcp.RA119.001800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sainio A, Järveläinen H. Extracellular matrix-cell interactions: Focus on therapeutic applications. Cell Signal 2020;66:109487. [PMID: 31778739 DOI: 10.1016/j.cellsig.2019.109487] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
62 Li Y, Song Y, Wang Z, Zhang Z, Lu M, Wang Y. Long Non-coding RNA LINC01787 Drives Breast Cancer Progression via Disrupting miR-125b Generation. Front Oncol 2019;9:1140. [PMID: 31750242 DOI: 10.3389/fonc.2019.01140] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
63 Jiang J, Shen N, Song W, Yu H, Sakurai K, Tang Z, Li G. Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously. Biomater Sci 2019;7:5283-91. [PMID: 31603448 DOI: 10.1039/c9bm01418g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
64 Ye F, Gao G, Zou Y, Zheng S, Zhang L, Ou X, Xie X, Tang H. circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer. Mol Ther Nucleic Acids 2019;18:88-98. [PMID: 31536884 DOI: 10.1016/j.omtn.2019.07.023] [Cited by in Crossref: 58] [Cited by in F6Publishing: 71] [Article Influence: 19.3] [Reference Citation Analysis]
65 Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J Exp Med. 2019;216:1016-1026. [PMID: 30975895 DOI: 10.1084/jem.20181827] [Cited by in Crossref: 132] [Cited by in F6Publishing: 144] [Article Influence: 44.0] [Reference Citation Analysis]